Bicara Therapeutics Inc. ...

12.13
0.37 (3.15%)
At close: Apr 17, 2025, 3:59 PM
12.16
0.25%
After-hours: Apr 17, 2025, 04:05 PM EDT

Bicara Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
-68M -59.48M -64.84M -58.41M -51.98M -39.55M -16.7M -8.35M
56K 55K 42K 30.5K 19K 5K 3K 1.5K
7.4M 4.98M 3.47M 2.68M 1.9M 1.13M 615K 307.5K
-14.16M 776K 1.07M 786.5K 502K -2.44M -880K -440K
-46K 911K 14.2M 9.07M 3.94M 3.26M -10.1M -5.05M
n/a n/a n/a n/a n/a n/a n/a n/a
-14.16M 776K 1.07M 786.5K 502K -2.44M -880K -440K
-74.75M -52.76M -46.06M -45.85M -45.63M -37.59M -27.06M -13.53M
-71K -467K -609K -597.5K -586K -150K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
62K 62K 62K 31K n/a n/a n/a n/a
-9K -405K -547K -566.5K -586K -150K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
335.08M 335.01M 955K 19.47M 37.98M 37.98M 37.89M 18.95M
334.03M 529.71M 235.47M 253.99M 272.5M 77.79M 37.89M 18.95M
285.86M 503.13M 215.45M 230.44M 230.44M 44.21M 14.99M n/a
-74.82M -53.22M -46.67M -46.44M -46.21M -37.74M -27.06M -13.53M